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Aseptic and automatable vitrification 





 Definition of hESCs cryopreservation conditions:
1. allowing recovery of live and biologically intact 
human embryonic cells (hESCs)
2. working in aseptic conditions
(EC directive 2004/23/EC)
3. using chemically defined media without human & 
animal serum (mTeSR1®)
4. compatible with automation
Definition of the optimal 
cryopreservation procedure
 Comparison of two methods of cryopreservation
• « Conventional » Slow Freezing (SLF) in 1 ml cryotubes
• Aseptic vitrification (Vit) in french straws
Prevalidation steps
 All conditions have been validated on:
• mouse embryos:
• Submitted paper : (work performed on zygotes)
Vitrification succeeds with lower intracellular concentration of cryoprotectants (ICCP) as 
compared to slow freezing, despite exposure to higher concentrations of cryoprotectant
solutions
Vanderzwalmen P, Connan D, Grobet L, Zech NH, Wirleitner B, Vanderzwalmen S, Nagy P,  
Ectors F. 
• mESCs
• cf: BEST presentation @ Lisbon (6/12/2011)
Definition of the optimal 
cryopreservation procedure
 Comparison of two methods of cryopreservation
on hESCs
• « Conventional » Slow Freezing (SLF) in 1 ml cryotubes
• Aseptic vitrification (Vit) in 0.16 ml french straws
mTeSR1® Serum DMSO
mTeSR1® Cryoprotectants
SLF as usually used for hESCs
 ~ 106 cells/ml
 10% DMSO – 40% KO-SR in mTeSR1®
 In cryotubes of 1 to 2 ml 
 Cooling rate: -1 to -2˚C/min until -80˚C, plunge in LN2





• Leaky to liquid N2 (>< to EU Tissue and Cells Directive 2004/23/EC)
• Poor control of supercooling  impair cell viability
Vitrification of hESCs
 Vitrification = extreme increase of viscosity upon very 
high speed cooling & warming (~1200˚C/min)
 Ultimately results in a solid amorphous state
From the bench and from the literature:
•Advantages
• No ice crystal formation
• No need of specific device for cooling & warming
•Drawbacks
• Use of high extracellular concentrations of 
cryoprotectants (but low intracellular [CPs])
In defined & serum-free medium
 hESCs cultured in defined serum-free medium: mTeSR1® 
Aseptic
 Sealed straw: no contact with LN2
(in compliance with EC recommendations)
Our vitrification procedure: 
Aseptic vitrification method:
cooling
500 g, 5 min
2 to 4 tubes
140 µL
+ 140 µL of Sol. 1 = 280 µL; incomplete equilibration1.:
+ 280 µL of Sol. 2 ; incomplete equilibration
Centrifugation @ 5000 g
Supernatant (560µL) removed
2.:
Pellet re-suspended in 160 µL of Sol. 3; no equilibration
Fill in straw immediately; seal at both ends








Identification plug hESCs in Sol. 3 Plug
92 mm french straw
= 0.16 ml
Mechanically sealed with a plug
Straw melted
with a thermosealer
133 mm: compatible with international standards of straw storage
Aseptic vitrification method:
warming
15 sec after thawing: + 1 mL of mTeSR1® = 2 mL of Suc 0.5M1.:
Straw thawed in
37ºC water bath 
30 sec after thawing: + 2 mL of mTeSR1® = 4 mL of Suc 0.25M2.:
60 sec after thawing: + 4 mL of mTeSR1® = 8 mL of Suc 0.125M
500 g during 5 min














3 & 7 d post-warming




Vitrified hESCs, d5, x40, picture #393
Pictures taken from the center of the well
Morphometric analysis
Vitrified hESCs, d5, x40
Picture taken from the center of the well
Morphometric analysis
Morphometric analysis:
Proliferation curves after warming of slow frozen vs vitrified cells
¼ well of a 6-well plate
hESCs proliferation curves after SF or V
Morphometric analysis:
Proliferation curves after warming of slow frozen vs vitrified cells
¼ well of a 6-well plate
hESCs proliferation curves after SF or V
Problem solved now
Karyotype analysis post-vitrification: 46XX
Immuno-histochemistry









 Aseptic vitrification of hESCs in defined media w/o
animal / human serum
 Stepwise addition and dilution of cryoprotectants
before cooling and after warming Automation
 Vitrified RCM1 cells maintain their stem state
Perspectives
 Multiple steps of vitrification





Thank you for your attention
